Schenone M, Dančík V, Wagner BK, Clemons PA. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol. 2013;2013:232–40.
Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules. 2018;23:250.
Article PubMed PubMed Central Google Scholar
Zhang L, Xu Z. Coumarin-containing hybrids and their anticancer activities. Eur J Med Chem. 2019;181:111587.
Article CAS PubMed Google Scholar
Rawat A, Vijaya Bhaskar Reddy A. Recent advances on anticancer activity of coumarin derivatives. Eur J Med Chem Reports. 2022;5:100038.
Wu XQ, Huang C, Jia YM, Song BA, Li J, Liu XH. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Eur J Med Chem. 2014;74:717–25.
Article CAS PubMed Google Scholar
Steinhilber D, Fischer AS, Metzner J, Steinbrink SD, Roos J, Ruthardt M, et al. 5-Lipoxygenase: Underappreciated role of a pro-inflammatory enzyme in tumorigenesis. Front Pharmacol. 2010;1:143.
Article CAS PubMed PubMed Central Google Scholar
van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: trends and lessons learned. Infect Dis Clin North Am. 2016;30:377–90.
Article PubMed PubMed Central Google Scholar
Patil SA, Nesaragi AR, Rodríguez-Berrios RR, Hampton SM, Bugarin A, Patil SA. Coumarin triazoles as potential antimicrobial agents. Antibiot. 2023;12:160.
Cheke RS, Patel HM, Patil VM, Ansari IA, Ambhore JP, Shinde SD, et al. Molecular insights into coumarin analogues as antimicrobial agents: Recent developments in drug discovery. Antibiot. 2022;11:566.
Strzelecka M, Świątek P. 1,2,4-Triazoles as important antibacterial agents. Pharmaceuticals (Basel). 2021;14:224. Mar 7
Article CAS PubMed Google Scholar
Bozorov K, Zhao J, Aisa HA. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview. Bioorg Med Chem. 2019;27:3511–31.
Article CAS PubMed PubMed Central Google Scholar
Hein JE, Fokin VV. Copper-catalyzed azide–alkyne cycloaddition (CuAAC) and beyond: New reactivity of copper(i) acetylides. Chem Soc Rev. 2010;39:1302–15.
Article CAS PubMed PubMed Central Google Scholar
Irby D, Du C, Li F. Lipid–drug conjugate for enhancing drug delivery. Mol Pharm. 2017;14:1325–38.
Article CAS PubMed PubMed Central Google Scholar
Tiwari VK, Mishra BB, Mishra KB, Mishra N, Singh AS, Chen X. Cu-catalyzed click reaction in carbohydrate chemistry. Chem Rev. 2016;116:3086–240.
Article CAS PubMed Google Scholar
Kumar D, Mishra KB, Mishra BB, Mondal S, Tiwari VK. Click chemistry inspired highly facile synthesis of triazolyl ethisterone glycoconjugates. Steroids. 2014;80:71–79.
Article CAS PubMed Google Scholar
Mishra KB, Mishra BB, Tiwari VK. Efficient synthesis of ethisterone glycoconjugate via bis-triazole linkage. Carbohydr Res. 2014;399:2–7.
Article CAS PubMed Google Scholar
Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nature Reviews Microbiology. 2004;2:123–40.
Article CAS PubMed Google Scholar
Ramos-Esteban JC, Servat JJ, Tauber S, Bia F. Bacillus megaterium delayed onset lamellar keratitis after LASIK. J Refract Surg. 2006;22:309–12.
Duncan KO, Smith TL. Primary cutaneous infection with Bacillus megaterium mimicking cutaneous anthrax. J Am Acad Dermatol. 2011;65:e60–1.
Guo Fu-Ping, Fan Hong-Wei, Liu Zheng-Yin, Yang Qi-Wei, Li Yi-Jia, Li Tai-Sheng. Brain abscess caused by Bacillus megaterium in an adult patient. Chin Med J (Engl). 2015;128:1552–4.
Aragaw WW, Lee BM, Yang X, Zimmerman MD, Gengenbacher M, Dartois V, et al. Potency boost of a mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F420H2-dependent reduction. Proc Natl Acad Sci USA. 2021;118:e2025172118.
Article CAS PubMed PubMed Central Google Scholar
McClendon AK, Osheroff N. DNA topoisomerase ii, genotoxicity, and cancer. Mutat. Res. - Fundam. Mol Mech Mutagen. 2007;623:83–97.
Boonthaworn K, Hengphasatporn K, Shigeta Y, Chavasiri W, Rungrotmongkol T, Ounjai P. In silico screening of chalcones and flavonoids as potential inhibitors against yellow head virus 3C-like protease. PeerJ. 2023;11:e15086.
Article PubMed PubMed Central Google Scholar
Li R, Sirawaraporn R, Chitnumsub P, Sirawaraporn W, Wooden J, Athappilly F, et al. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. J Mol Biol. 2000;295:307–23.
Article CAS PubMed Google Scholar
Al-Thubiani ASA, Maher YA, Fathi A, Abourehab M, Alarjah M, Khan M, et al. Identification and characterization of a novel antimicrobial peptide compound produced by bacillus megaterium strain isolated from oral microflora. Saudi Pharm J. 2018;26:1089–97.
Article PubMed PubMed Central Google Scholar
https://www.rcsb.org/structure/1DF7.
Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer. 2006;6:813–23.
Comments (0)